Dual vs. isolated anti-Ro antibody positivity in rheumatoid arthritis
Anti-Ro antibody subtyping effectively identifies distinct clinical and immunological RA subgroups. Patients with isolated Ro60 antibody positivity display a relatively less severe clinical profile compared to those with dual antibody positivity, highlighting the importance of specific antibody profiles in guiding personalized clinical management and therapeutic decision-making.
Authors
- Chaoyu Gu (ORCID: https://orcid.org/0009-0004-1131-8441)
- Liangjing Lu (ORCID: https://orcid.org/0000-0001-9116-6038)
- Yan Ma (ORCID: https://orcid.org/0000-0002-5242-1339)
- Qianqian Li (ORCID: https://orcid.org/0000-0002-7508-2130)
Institutions
- Renji Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.3389/fimmu.2025.1661334
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China